Orbimed Advisors LLC Portfolio Holdings

Orbimed Advisors LLC

  • $4.44 Billion
  • Q1 2024

Orbimed Advisors LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $4.44 Billion distributed in 115 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $281M, Edgewise Therapeutics, Inc. with a value of $274M, Boston Scientific Corp with a value of $224M, Intuitive Surgical Inc with a value of $197M, and Biogen Inc. with a value of $194M.

Examining the 13F form we can see an increase of $361M in the current position value, from $4.08B to 4.44B.

Orbimed Advisors LLC is based out at San Diego, CA

Below you can find more details about Orbimed Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $4.44 Billion
Healthcare: $4.44 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$779B
$281 Million 6.32% of portfolio
360,800
Q1 2024 Reduced 1.26%
$1.08B
$274 Million 6.17% of portfolio
15,021,721
Q1 2024 Added 3.12%
$108B
$224 Million 5.05% of portfolio
3,273,000
Q1 2024 Reduced 1.02%
$142B
$197 Million 4.43% of portfolio
493,100
Q1 2024 Reduced 1.18%
$32.4B
$194 Million 4.37% of portfolio
900,900
Q1 2024 Added 8.86%
$318B
$174 Million 3.91% of portfolio
1,316,000
Q1 2024 Added 24.74%
$2.23B
$161 Million 3.62% of portfolio
4,275,553
Q1 2024 Added 28.86%
$14.6B
$123 Million 2.78% of portfolio
1,173,300
Q1 2024 Reduced 4.17%
$13.9B
$112 Million 2.51% of portfolio
1,278,500
Q1 2024 Reduced 18.64%
$0
$106 Million 2.39% of portfolio
2,680,496
Q1 2024 Added 5.73%
$129B
$96.3 Million 2.17% of portfolio
269,000
Q3 2023 Reduced 0.88%
$11.4B
$90.3 Million 2.03% of portfolio
697,500
Q4 2023 Added 31.8%
$129B
$87.2 Million 1.96% of portfolio
168,100
Q1 2024 Added 18.8%
$5.33B
$87.3 Million 1.96% of portfolio
2,013,033
Q1 2024 Reduced 2.51%
$77.9M
$85.5 Million 1.93% of portfolio
73,114,592
Q3 2022 Added 0.23%
$2.06B
$85.4 Million 1.92% of portfolio
2,605,615
Q1 2024 Reduced 5.13%
$1.21B
$84 Million 1.89% of portfolio
1,268,734
Q4 2023 Reduced 16.24%
$10.3B
$82.3 Million 1.85% of portfolio
899,431
Q1 2024 Reduced 5.77%
$223B
$76.7 Million 1.73% of portfolio
132,000
Q1 2024 Reduced 8.21%
$4.31B
$76.3 Million 1.72% of portfolio
1,297,800
Q1 2024 Added 40.73%
$4.17B
$72.8 Million 1.64% of portfolio
1,066,131
Q1 2024 Reduced 7.54%
$2.39B
$64.8 Million 1.46% of portfolio
1,385,000
Q1 2024 Reduced 16.93%
$485M
$63.5 Million 1.43% of portfolio
3,574,632
Q1 2024 Reduced 15.79%
$20.5B
$59.7 Million 1.34% of portfolio
151,600
Q1 2024 Added 79.2%
$26.5B
$58.5 Million 1.32% of portfolio
174,100
Q1 2024 Added 31.69%
$13B
$58.4 Million 1.31% of portfolio
423,100
Q1 2024 Reduced 18.52%
$537M
$54.6 Million 1.23% of portfolio
5,779,071
Q3 2022 New
$736M
$54.7 Million 1.23% of portfolio
3,398,067
Q1 2024 Reduced 10.05%
$172M
$52.9 Million 1.19% of portfolio
4,003,967
Q4 2023 Reduced 0.21%
$482M
$52 Million 1.17% of portfolio
3,174,521
Q1 2024 Added 38.47%
$140M
$51.7 Million 1.16% of portfolio
10,909,256
Q2 2023 Added 8.66%
$117B
$51.3 Million 1.15% of portfolio
122,700
Q1 2024 Reduced 29.97%
$226M
$50 Million 1.13% of portfolio
7,619,135
Q4 2022 Added 1.84%
$4.57B
$47.9 Million 1.08% of portfolio
682,700
Q1 2024 New
$143M
$44.3 Million 1.0% of portfolio
22,362,850
Q4 2022 Added 1.83%
$1.34B
$42.5 Million 0.96% of portfolio
12,893,611
Q1 2024 Added 2,558.48%
$1.09B
$41.6 Million 0.94% of portfolio
1,749,000
Q4 2023 Added 36.21%
$144M
$36.7 Million 0.83% of portfolio
13,708,731
Q1 2024 New
$463B
$34.6 Million 0.78% of portfolio
70,000
Q3 2023 Reduced 71.31%
$1.99B
$30.5 Million 0.69% of portfolio
704,842
Q1 2024 Added 31.34%
$433M
$30.3 Million 0.68% of portfolio
2,717,970
Q1 2024 Reduced 12.18%
$1.03B
$29.1 Million 0.66% of portfolio
675,872
Q1 2024 Reduced 55.48%
$439M
$28 Million 0.63% of portfolio
10,111,550
Q1 2024 Added 70.56%
$107M
$27.9 Million 0.63% of portfolio
5,559,528
Q4 2022 Added 15.89%
$58M
$26.9 Million 0.61% of portfolio
11,447,140
Q1 2024 Added 37.55%
$1.4B
$25.4 Million 0.57% of portfolio
994,100
Q1 2024 New
$2.37B
$23.7 Million 0.53% of portfolio
550,000
Q4 2023 Reduced 42.64%
$105B
$21.9 Million 0.49% of portfolio
22,800
Q1 2024 Added 68.89%
$2.43B
$21.2 Million 0.48% of portfolio
739,651
Q1 2024 Added 131.39%

Summary

  • Portfolio
  • No. of Stocks 115
  • Current Value $4.44 Billion
  • Prior Value $4.08 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 20 stocks
  • Additional Purchases 22 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 29 stocks
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email